|
CKAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.16820000024043E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52082000000053E-05 |
| Normal-vs-Stage2 |
1.299850E-03 |
| Normal-vs-Stage3 |
6.430800E-04 |
| Normal-vs-Stage4 |
4.80609999997661E-06 |
| Stage1-vs-Stage2 |
4.360400E-01 |
| Stage1-vs-Stage3 |
7.083600E-01 |
| Stage1-vs-Stage4 |
8.387600E-02 |
| Stage2-vs-Stage3 |
3.299400E-01 |
| Stage2-vs-Stage4 |
5.816800E-01 |
| Stage3-vs-Stage4 |
7.015900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.82740000301374E-08 |
| Normal-vs-AfricanAmerican |
1.098850E-01 |
| Normal-vs-Asian |
7.695600E-02 |
| Caucasian-vs-AfricanAmerican |
2.266200E-02 |
| Caucasian-vs-Asian |
4.200000E-01 |
| AfricanAmerican-vs-Asian |
8.125600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27699999755649E-08 |
| Normal-vs-Female |
2.15000000000076E-05 |
| Male-vs-Female |
2.958200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.210070E-02 |
| Normal-vs-Age(41-60Yrs) |
2.30529999978302E-07 |
| Normal-vs-Age(61-80Yrs) |
1.59700000001983E-06 |
| Normal-vs-Age(81-100Yrs) |
8.179700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.727600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.651800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.850000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.092200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.634600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.570800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.897500E-02 |
| Normal-vs-Grade 2 |
1.89530000005433E-06 |
| Normal-vs-Grade 3 |
8.23459999965692E-07 |
| Normal-vs-Grade 4 |
2.420600E-04 |
| Grade 1-vs-Grade 2 |
4.667600E-01 |
| Grade 1-vs-Grade 3 |
3.861000E-01 |
| Grade 1-vs-Grade 4 |
2.544600E-01 |
| Grade 2-vs-Grade 3 |
8.118400E-01 |
| Grade 2-vs-Grade 4 |
4.647600E-01 |
| Grade 3-vs-Grade 4 |
5.573200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.67960000025036E-07 |
| Normal-vs-ccB subtype |
1.42359999999453E-06 |
| ccA subtype-vs-ccB subtype |
7.242400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21420000007444E-07 |
| Normal-vs-N1 |
4.540700E-03 |
| N0-vs-N1 |
1.927510E-02 |
|
|
